Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Copy number alterations associated with clinical features in an underrepresented population with breast cancer.

Rodrigues-Peres RM, de S Carvalho B, Anurag M, Lei JT, Conz L, Gonçalves R, Cardoso Filho C, Ramalho S, de Paiva GR, Derchain SFM, Lopes-Cendes I, Ellis MJ, Sarian LO.

Mol Genet Genomic Med. 2019 May 16:e750. doi: 10.1002/mgg3.750. [Epub ahead of print]

2.

DNA damage repair defects as a new class of endocrine treatment resistance driver.

Anurag M, Ellis MJ, Haricharan S.

Oncotarget. 2018 Nov 20;9(91):36252-36253. doi: 10.18632/oncotarget.26363. eCollection 2018 Nov 20. No abstract available.

3.

Author Correction: The prognostic effects of somatic mutations in ER-positive breast cancer.

Griffith OL, Spies NC, Anurag M, Griffith M, Luo J, Tu D, Yeo B, Kunisaki J, Miller CA, Krysiak K, Hundal J, Ainscough BJ, Skidmore ZL, Campbell K, Kumar R, Fronick C, Cook L, Snider JE, Davies S, Kavuri SM, Chang EC, Magrini V, Larson DE, Fulton RS, Liu S, Leung S, Voduc D, Bose R, Dowsett M, Wilson RK, Nielsen TO, Mardis ER, Ellis MJ.

Nat Commun. 2018 Nov 14;9(1):4850. doi: 10.1038/s41467-018-07407-3.

4.

The prognostic effects of somatic mutations in ER-positive breast cancer.

Griffith OL, Spies NC, Anurag M, Griffith M, Luo J, Tu D, Yeo B, Kunisaki J, Miller CA, Krysiak K, Hundal J, Ainscough BJ, Skidmore ZL, Campbell K, Kumar R, Fronick C, Cook L, Snider JE, Davies S, Kavuri SM, Chang EC, Magrini V, Larson DE, Fulton RS, Liu S, Leung S, Voduc D, Bose R, Dowsett M, Wilson RK, Nielsen TO, Mardis ER, Ellis MJ.

Nat Commun. 2018 Sep 4;9(1):3476. doi: 10.1038/s41467-018-05914-x. Erratum in: Nat Commun. 2018 Nov 14;9(1):4850.

5.

Functional Annotation of ESR1 Gene Fusions in Estrogen Receptor-Positive Breast Cancer.

Lei JT, Shao J, Zhang J, Iglesia M, Chan DW, Cao J, Anurag M, Singh P, He X, Kosaka Y, Matsunuma R, Crowder R, Hoog J, Phommaly C, Goncalves R, Ramalho S, Peres RMR, Punturi N, Schmidt C, Bartram A, Jou E, Devarakonda V, Holloway KR, Lai WV, Hampton O, Rogers A, Tobias E, Parikh PA, Davies SR, Li S, Ma CX, Suman VJ, Hunt KK, Watson MA, Hoadley KA, Thompson EA, Chen X, Kavuri SM, Creighton CJ, Maher CA, Perou CM, Haricharan S, Ellis MJ.

Cell Rep. 2018 Aug 7;24(6):1434-1444.e7. doi: 10.1016/j.celrep.2018.07.009.

6.

Comprehensive Profiling of DNA Repair Defects in Breast Cancer Identifies a Novel Class of Endocrine Therapy Resistance Drivers.

Anurag M, Punturi N, Hoog J, Bainbridge MN, Ellis MJ, Haricharan S.

Clin Cancer Res. 2018 Oct 1;24(19):4887-4899. doi: 10.1158/1078-0432.CCR-17-3702. Epub 2018 May 23.

PMID:
29793947
7.

Loss of MutL Disrupts CHK2-Dependent Cell-Cycle Control through CDK4/6 to Promote Intrinsic Endocrine Therapy Resistance in Primary Breast Cancer.

Haricharan S, Punturi N, Singh P, Holloway KR, Anurag M, Schmelz J, Schmidt C, Lei JT, Suman V, Hunt K, Olson JA Jr, Hoog J, Li S, Huang S, Edwards DP, Kavuri SM, Bainbridge MN, Ma CX, Ellis MJ.

Cancer Discov. 2017 Oct;7(10):1168-1183. doi: 10.1158/2159-8290.CD-16-1179. Epub 2017 Aug 11.

8.

Amplification of TLK2 Induces Genomic Instability via Impairing the G2-M Checkpoint.

Kim JA, Anurag M, Veeraraghavan J, Schiff R, Li K, Wang XS.

Mol Cancer Res. 2016 Oct;14(10):920-927. Epub 2016 Aug 3.

9.

Crowd sourcing a new paradigm for interactome driven drug target identification in Mycobacterium tuberculosis.

Vashisht R, Mondal AK, Jain A, Shah A, Vishnoi P, Priyadarshini P, Bhattacharyya K, Rohira H, Bhat AG, Passi A, Mukherjee K, Choudhary KS, Kumar V, Arora A, Munusamy P, Subramanian A, Venkatachalam A, Gayathri S, Raj S, Chitra V, Verma K, Zaheer S, Balaganesh J, Gurusamy M, Razeeth M, Raja I, Thandapani M, Mevada V, Soni R, Rana S, Ramanna GM, Raghavan S, Subramanya SN, Kholia T, Patel R, Bhavnani V, Chiranjeevi L, Sengupta S, Singh PK, Atray N, Gandhi S, Avasthi TS, Nisthar S, Anurag M, Sharma P, Hasija Y, Dash D, Sharma A, Scaria V, Thomas Z; OSDD Consortium, Chandra N, Brahmachari SK, Bhardwaj A.

PLoS One. 2012;7(7):e39808. doi: 10.1371/journal.pone.0039808. Epub 2012 Jul 11.

10.

Location of disorder in coiled coil proteins is influenced by its biological role and subcellular localization: a GO-based study on human proteome.

Anurag M, Singh GP, Dash D.

Mol Biosyst. 2012 Jan;8(1):346-52. doi: 10.1039/c1mb05210a. Epub 2011 Oct 25.

PMID:
22027861
11.

A web server for predicting inhibitors against bacterial target GlmU protein.

Singla D, Anurag M, Dash D, Raghava GP.

BMC Pharmacol. 2011 Jul 6;11:5. doi: 10.1186/1471-2210-11-5.

12.

Unraveling the potential of intrinsically disordered proteins as drug targets: application to Mycobacterium tuberculosis.

Anurag M, Dash D.

Mol Biosyst. 2009 Dec;5(12):1752-7. doi: 10.1039/B905518p. Epub 2009 Jul 15.

PMID:
19763328
13.

Camptocormia - a case report.

Chauhan S, Anurag MS, Jain RK.

Indian J Psychiatry. 1985 Jan;27(1):101-2. No abstract available.

Supplemental Content

Loading ...
Support Center